Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna greaves brewster llp
no operation time available
2 offices
active in Legal Services

We have observed 59 EP applications David Richard Spinner has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 24, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12720055

METHODS OF TREATING SQUAMOUS CELL CARCINOMA RELATED APPLICATIONS

IPC classification:
G01N 33/574
Applicant:
Novartis AG
Agent:
David Richard Spinner, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12836762

SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA

IPC classification:
C12Q 1/48
Agent:
David Richard Spinner, Greaves Brewster LLP
Agent:
Philippe Ahner, Brevalex
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12720757

METHOD OF TREATING VISION DISORDERS

IPC classification:
C07K 16/22, A61P 27/02
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13760262

DEVICE FOR MANUFACTURING POLYMER FIBERS AND USES THEREOF

IPC classification:
A61L 33/06, D01D 5/38, D01D 5/30, B29C 47/00
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13777952

METHOD OF TREATING AN OCULAR DISEASE AND COMPOSITIONS EFFECTIVE FOR TREATING AN OCULAR DISEASE

IPC classification:
A61K 38/13
Applicant:
Howard University
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP13798068

SELECTIVE BINDING OF BIOLOGICAL TARGETS TO SOLID PHASE UREIDES

IPC classification:
G01N 33/48, C12N 7/02, B01D 15/00
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
The patent has been granted
EP13796498

MIXED MULTIFUNCTIONAL METAL AFFINITY SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS FIELD

IPC classification:
C07K 1/18, C07C 259/06, C07C 233/47, C07C 211/14, C07C 55/22, C07C 55/02, B01D 39/00, B01D 15/38, B01D 15/36
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13810714

RECONSTITUTION DEVICE

IPC classification:
A61M 5/315, A61M 5/28
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13810751

INDUCTION OF ESTROGEN RECEPTOR BETA BY CHOLESTEROL BIOSYNTHESIS INHIBITORS AND METHODS OF TREATMENT OF CANCER

IPC classification:
A61K 31/5685, A61K 31/56, A61P 35/00
Applicant:
University Of Missouri
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP13813988

ANTIBODIES TO TAU

IPC classification:
G01N 33/53, C07K 16/18
Applicant:
Washington University
Agent:
J A Kemp
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13762842

SALMONID ALPHAVIRUS AND USES THEREOF

IPC classification:
A61K 39/12, G01N 33/569, C07K 14/18
Applicant:
Novartis Tiergesundheit AG
Agent:
Sean Matthew Alexander, Eli Lilly and Company Limited
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
PATENT GRANTED
EP13839678

GROUPING FOR CLASSIFYING GASTRIC CANCER

IPC classification:
G01N 33/574, C12Q 1/68
Applicant:
Agency for Science, Technology and Research
Applicant:
National University of Singapore
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP13789453

FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

IPC classification:
C12Q 1/68, C07K 14/005
Applicant:
Center for Technology Licensing (CTL) at Cornell University
Applicant:
Novartis Tiergesundheit AG
Applicant:
Cornell University
Agent:
Sean Matthew Alexander, Eli Lilly and Company Limited
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
The patent has been granted
EP13859964

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
A61K 45/00
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP15163041

CELL LINE AND METHODS FOR IMPROVED GLYCOPROTEIN SIALYLATION

IPC classification:
C12P 21/06, C12P 21/04, C12N 15/113, C12N 9/24
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP14751487

A POLYMERIC SYSTEM FOR RELEASE OF AN ACTIVE AGENT

IPC classification:
A61K 47/48, A61K 47/30, A61L 27/50, A61L 27/44
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP14726176

INTERACTIONS OF BETANODAVIRUSES IN INFECTION

IPC classification:
A61K 39/12
Applicant:
University of Málaga (Universidad de Malaga)
Applicant:
Novartis Tiergesundheit AG
Agent:
Sean Matthew Alexander, Eli Lilly and Company Limited
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP14748051

METHODS FOR PREPARING INACTIVATED ROTAVIRUS

IPC classification:
C12N 7/00, A61K 39/12
Applicant:
Novartis Tiergesundheit AG
Agent:
Sean Matthew Alexander, Eli Lilly and Company Limited
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP15202325

PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND A METHOD FOR MAKING THE SAME

IPC classification:
C12N 15/82
Applicant:
BASF Plant Science Company GmbH
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION PUBLISHED
EP14843476

SYNTHETIC POLYMERIC MATERIALS AND DEVICES THEREOF

IPC classification:
C08G 63/91, C08L 43/04, C08G 77/20
Applicant:
Colorado State University Research Foundation
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP14846178

SEMI-AUTOMATIC SPHYGMOMANOMETER SYSTEM

IPC classification:
A61B 5/0225
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP14845825

IMMUNOASSAYS USING OVER-LABELED FLUORESCENT PROBES

IPC classification:
G01N 33/53
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
GRANT OF PATENT INTENDED
EP14856488

INTRA-AMNIOTIC ADMINISTRATION OF PROTEINS FOR THE TREATMENT OF ECTODERMAL DYSPLASIAS

IPC classification:
A61K 38/00, A61K 39/00
Applicant:
University of Erlangen-Nürnberg (Friedrich-Alexander-Universität Erlangen-Nürnberg)
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16155761

METHOD FOR TREATMENT OF DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE

IPC classification:
A61K 38/21, C07K 14/535, A61P 37/00, A61P 25/28, A61P 25/00, A61K 38/19
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16158001

METHODS OF DETERMINING AMYLOID BETA TURNOVER IN BLOOD

IPC classification:
G01N 33/68, G01N 33/48, A61B 5/00
Applicant:
Washington University
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
The patent has been granted
EP14872184

MICRO RNA ISOLATION FROM BIOLOGICAL FLUID

IPC classification:
G01N 33/566, C12Q 1/68, G01N 33/53, C07H 21/04
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP14830849

BIOMARKERS AND METHODS RELATING TO ALZHEIMER'S DISEASE

IPC classification:
G01N 33/68
Applicant:
King's College London
Agent:
Matthew David Greenwood, Bryers LLP
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15701433

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF AMINO ACIDS IN HYDROGENOTROPHIC MICROORGANISMS

IPC classification:
C12R 1/01
Agent:
Anna Louise Gregson, Mathys & Squire LLP
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16166821

OLIGONUCLEOTIDES FOR MAKING A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE PRESENT IN A LIVING CELL

IPC classification:
A61K 31/7088, A61K 48/00, C12N 15/11
Agent:
David Richard Spinner, Greaves Brewster LLP
Agent:
Carpmaels & Ransford LLP
Status:
The patent has been granted
EP15748750

ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/167
Applicant:
University of Arkansas
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15782530

INTEGRATED CELLULOSIC ETHANOL PRODUCTION PROCESS

IPC classification:
A23L 7/104, A23L 29/30, A23L 29/212, C12P 7/10, C12P 7/06, C12N 1/16
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183719

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/63, C12N 15/10
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION PUBLISHED
EP16183725

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/63, C12N 15/10
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION IN PROGRESS
EP15786641

EPIGENETIC MODIFICATION OF MAMMALIAN GENOMES USING TARGETED ENDONUCLEASES

IPC classification:
C12Q 1/02, C12Q 1/68
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183724

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/63, C12N 15/10
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183717

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/63, C12N 15/10
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION PUBLISHED
EP15746604

PROCESS FOR THE PREPARATION OF A C5-ENRICHED JUICE STREAM

IPC classification:
C08B 30/00
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP16183723

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/63, C12N 15/10
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
The patent has been granted
EP16183720

CRISPR-BASED GENOME MODIFICATION AND REGULATION

IPC classification:
C12N 9/22, C12N 15/63, C12N 15/10
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
APPLICATION PUBLISHED
EP16195608

TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES

IPC classification:
C12N 15/62, A61P 35/00, C07K 16/32, A61K 38/21
Applicant:
University of California
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15734489

BOTTOM LOADED PEDICLE SCREW

IPC classification:
A61B 17/70
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
EXAMINATION REQUESTED
EP15842126

ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS

IPC classification:
A01P 1/00, A61P 31/00, A01N 43/50, A61K 31/4178, C07D 233/56
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP17159129

BIOMARKERS OF OSTEOARTHRITIS

IPC classification:
G01N 33/53, C12Q 1/68
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
The application has been published
EP15846448

TAU KINETIC MEASUREMENTS

IPC classification:
G01N 33/58, G01N 33/68, A61K 51/02, A61K 51/08
Applicant:
Washington University
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP15848503

GLYCAN ANALYSIS AND PROFILING

IPC classification:
C40B 40/12
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP15784712

OLIGONUCLEOTIDES FOR GENOMIC DNA EDITING

IPC classification:
A61K 31/7088, C12N 15/11
Agent:
David Richard Spinner, Greaves Brewster LLP
Agent:
Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15859152

GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

IPC classification:
C07K 16/00, A61K 39/00, A61K 39/395
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP15813826

TARGETED RNA EDITING

IPC classification:
C12N 15/113
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP15874292

VISUALIZING MODIFIED NUCLEOTIDES AND NUCLEIC ACID INTERACTIONS IN SINGLE CELLS

IPC classification:
G01N 33/50, C12Q 1/68, C12N 15/09
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP16743810

NANOCAPSULES CARRYING CHIKUNGUNYA-ASSOCIATED PEPTIDES

IPC classification:
A61K 9/51, C07K 19/00, C07K 14/18, A61K 39/12
Applicant:
Nanyang Technological University
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP16752970

HIGH SENSITIVITY METHOD FOR EARLY LYME DISEASE DETECTION

IPC classification:
G01N 33/569, G01N 27/62, G01N 30/72
Applicant:
Colorado State University Research Foundation
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP16755992

METHODS AND COMPOSITIONS FOR EXPANSION AND DIFFERENTIATION OF SKELETAL MUSCLE STEM CELLS OR PROGENITOR CELLS

IPC classification:
C12N 5/077
Applicant:
Agency for Science, Technology and Research
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP16707414

OLIGONUCLEOTIDE THERAPY FOR LEBER CONGENITAL AMAUROSIS

IPC classification:
A61K 31/7125, A61K 31/712, C12N 15/113
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP16709465

OLIGONUCLEOTIDES MATCHING COL7A1 EXON 73 FOR EPIDERMOLYSIS BULLOSA THERAPY

IPC classification:
A61K 31/7125, A61K 31/712, C12N 15/113
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP17157024

USING PROGRAMMABLE DNA BINDING PROTEINS TO ENHANCE TARGETED GENOME MODIFICATION

IPC classification:
C12N 9/22, C12N 15/10
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP16725977

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF METHIONINE

IPC classification:
C12M 1/00, C07K 14/195, C12N 9/88, C12N 9/02, C12P 13/12
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP16724048

ANTISENSE OLIGONUCLEOTIDES TO TREAT DYSTROPHIC EPIDERMOLYSIS BULLOSA

IPC classification:
A61K 31/7088, A61P 17/00, C12N 15/113
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP16800544

METHODS FOR NEXT GENERATION GENOME WALKING AND RELATED COMPOSITIONS AND KITS

IPC classification:
C40B 20/04, C07H 21/04, C12P 19/34, C12Q 1/68
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
Request for examination was made
EP17202931

FUTURE CARDIAC EVENT BIOMARKERS

IPC classification:
A61P 9/00, G01N 33/68
Applicant:
Leiden University (Universiteit Leiden)
Applicant:
Leiden University Medical Center (Leids Universitair Medisch Centrum (LUMC) - Academisch Ziekenhuis Leiden)
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
The application has been published

Please Sign in to use this feature